ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 83 filers reported holding ONCOMED PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,234,000 | -25.0% | 534,309 | +3.3% | 0.01% | -21.4% |
| Q1 2018 | $1,645,000 | -23.1% | 517,223 | -0.9% | 0.01% | -17.6% |
| Q4 2017 | $2,140,000 | -9.3% | 521,883 | 0.0% | 0.02% | -5.6% |
| Q3 2017 | $2,359,000 | +38.2% | 521,883 | +1.8% | 0.02% | +28.6% |
| Q2 2017 | $1,707,000 | -73.8% | 512,563 | -27.4% | 0.01% | -73.6% |
| Q1 2017 | $6,504,000 | +22.4% | 706,240 | +2.5% | 0.05% | +20.5% |
| Q4 2016 | $5,314,000 | -46.6% | 689,254 | -20.9% | 0.04% | -52.2% |
| Q3 2016 | $9,959,000 | +87.4% | 871,302 | +101.8% | 0.09% | +84.0% |
| Q2 2016 | $5,315,000 | +61.7% | 431,730 | +32.8% | 0.05% | +66.7% |
| Q1 2016 | $3,286,000 | -8.4% | 325,000 | +104.1% | 0.03% | -21.1% |
| Q4 2015 | $3,588,000 | +4.7% | 159,198 | -22.9% | 0.04% | -5.0% |
| Q3 2015 | $3,426,000 | -59.4% | 206,483 | -45.0% | 0.04% | -18.4% |
| Q2 2015 | $8,442,000 | +105.3% | 375,170 | +135.1% | 0.05% | -14.0% |
| Q1 2015 | $4,113,000 | -25.2% | 159,551 | -36.9% | 0.06% | -39.4% |
| Q4 2014 | $5,498,000 | -4.1% | 252,658 | -16.6% | 0.09% | -20.3% |
| Q3 2014 | $5,734,000 | -1.7% | 302,915 | +21.0% | 0.12% | -9.2% |
| Q2 2014 | $5,835,000 | -33.8% | 250,434 | -4.3% | 0.13% | -46.3% |
| Q1 2014 | $8,808,000 | +6.7% | 261,763 | -6.4% | 0.24% | -25.8% |
| Q4 2013 | $8,253,000 | +100.4% | 279,580 | +3.9% | 0.33% | +94.0% |
| Q3 2013 | $4,118,000 | – | 268,997 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 4,108,815 | $4,273,000 | 0.48% |
| Birchview Capital, LP | 372,557 | $387,000 | 0.24% |
| Perceptive Advisors | 1,719,111 | $1,787,000 | 0.05% |
| Fondren Management LP | 25,136 | $26,000 | 0.02% |
| Cannell & Co. | 281,983 | $293,000 | 0.01% |
| APPLETON PARTNERS INC/MA | 66,206 | $69,000 | 0.01% |
| Quinn Opportunity Partners LLC | 66,162 | $69,000 | 0.01% |
| NJ State Employees Deferred Compensation Plan | 38,000 | $40,000 | 0.01% |
| Candriam S.C.A. | 380,000 | $395,000 | 0.01% |
| PRIMECAP MANAGEMENT CO/CA/ | 5,451,400 | $5,669,000 | 0.00% |